Bruchovsky N, Rennie P S, Coldman A J, Goldenberg S L, To M, Lawson D
Department of Cancer Endocrinology, University of British Columbia, Vancouver, Canada.
Cancer Res. 1990 Apr 15;50(8):2275-82.
The parent Shionogi mouse mammary carcinoma is androgen dependent but cells that survive hormone withdrawal progress and give rise to an androgen-independent tumor. To determine whether renewed growth might be attributed to the persistence or partial recovery of an androgenic stimulus, we compared the amount of dihydrotestosterone and nuclear androgen receptor in parent and recurrent tumors. The whole tissue concentration of dihydrotestosterone in the parent tumor before castration was 1.40 +/- 0.46 (SE) as compared with 0.22 +/- 0.10 pmol/mg of DNA in the recurrent tumor. The initial concentration of nuclear androgen receptor in the parent was 0.65 +/- 0.12 pmol/mg of DNA; this was reduced to zero within 24 h after castration. Also in keeping with the androgen independence, no receptor was detected in the nuclear fraction of the recurrent carcinoma. In an attempt to relate malignant potential to nonhormonal factors associated with progression, we compared the proportions of androgen-dependent and -independent tumorigenic (stem) cells in parent and recurrent tumors using an in vivo limiting dilution assay. The difference observed, i.e., one stem cell per 4000 tumor cells in the parent versus one stem cell per 200 tumor cells in the recurrent carcinoma, was consistent with a marked enrichment of stem cells in the latter. The proportion of androgen-independent stem cells was also determined by assaying tumor takes in female hosts. The difference, i.e., one stem cell per 370,000 tumor cells in the parent versus one stem cell per 800 tumor cells in the recurrent carcinoma, demonstrated a striking 500-fold increase in androgen-independent stem cells resulting from androgen withdrawal. Unexpectedly, no enrichment of androgen-independent stem cells was evident in regressing parent tumors; rather, the proportion of such cells was very small, i.e., one androgen-independent stem cell per 2,200,000 regressing parent cells. This finding implies that the androgen-independent state of cells which survive androgen withdrawal may result from the ability of a small number of initially androgen-dependent stem cells to adapt to an altered hormone environment.
亲代盐野义小鼠乳腺癌依赖雄激素,但在激素撤除后存活的细胞会继续发展并产生雄激素非依赖性肿瘤。为了确定肿瘤的再次生长是否归因于雄激素刺激的持续存在或部分恢复,我们比较了亲代肿瘤和复发性肿瘤中双氢睾酮的含量以及核雄激素受体的情况。去势前亲代肿瘤中双氢睾酮的全组织浓度为1.40±0.46(标准误),而复发性肿瘤中为0.22±0.10 pmol/mg DNA。亲代肿瘤中核雄激素受体的初始浓度为0.65±0.12 pmol/mg DNA;去势后24小时内该浓度降至零。同样与雄激素非依赖性一致的是,在复发性癌的核组分中未检测到受体。为了将恶性潜能与进展相关的非激素因素联系起来,我们使用体内极限稀释分析法比较了亲代肿瘤和复发性肿瘤中雄激素依赖性和非依赖性致瘤(干细胞)细胞的比例。观察到的差异,即亲代肿瘤中每4000个肿瘤细胞中有一个干细胞,而复发性癌中每200个肿瘤细胞中有一个干细胞,这与后者中干细胞的显著富集一致。通过检测雌性宿主中的肿瘤形成情况也确定了雄激素非依赖性干细胞的比例。差异为,亲代肿瘤中每370,000个肿瘤细胞中有一个干细胞,而复发性癌中每800个肿瘤细胞中有一个干细胞,这表明雄激素撤除导致雄激素非依赖性干细胞显著增加了500倍。出乎意料的是,在消退的亲代肿瘤中未明显富集雄激素非依赖性干细胞;相反,这类细胞的比例非常小,即每2,200,000个消退的亲代细胞中有一个雄激素非依赖性干细胞。这一发现意味着,在雄激素撤除后存活的细胞的雄激素非依赖性状态可能源于少数最初依赖雄激素的干细胞适应改变的激素环境的能力。